TY - JOUR
T1 - First successful hemoadsorption using CytoSorb® in a septic pediatric patient in Kazakhstan
T2 - A case report
AU - Sazonov, Vitaliy
AU - Saparov, Askhat
AU - Tobylbaeva, Zaure
AU - Isakov, Samat
AU - Bekpan, Almat
AU - Autalipov, Darkhan
AU - Muratbekova, Bakhyt
AU - Manaybekova, Zhazira
AU - Anikin, Vitaliy
PY - 2019/6/1
Y1 - 2019/6/1
N2 - Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.
AB - Purpose: For the first time in Kazakhstan, we have used a combined extracorporeal support, by including the CytoSorb system in a continuous veno-venous hemofiltration system in an 8-month-old patient with a body weight of 5600 g. Results: The CytoSorb therapy session resulted in a reduction of inflammation markers IL-6, S100, procalcitonin, and C-reactive protein. Simultaneously, the level of transaminases, creatine kinase, and troponin were normalized, by the end of the session patient hemodynamics were stable and there was no need for vasopressors, acid–base balance was maintained, and the patient was weaned from mechanical ventilation to spontaneous breathing. Conclusion: Treatment using the CytoSorb device was safe and well-tolerated in a pediatric patient and has proven its practical value as an adjuvant therapy for sepsis in pediatric patient populations.
KW - chronic tracheal cannulation
KW - CytoSorb
KW - hemoadsorption
KW - pediatric population
KW - pediatric sepsis
KW - pneumonia
KW - Sepsis
KW - septic shock
KW - severe laryngeal stenosis
UR - http://www.scopus.com/inward/record.url?scp=85060099964&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85060099964&partnerID=8YFLogxK
U2 - 10.1177/0391398818819953
DO - 10.1177/0391398818819953
M3 - Article
C2 - 30614343
AN - SCOPUS:85060099964
VL - 42
SP - 315
EP - 317
JO - International Journal of Artificial Organs
JF - International Journal of Artificial Organs
SN - 0391-3988
IS - 6
ER -